glutathione and nqo1 Review on NAD(P)H dehydrogenase quinone 1 (NQO1) pathway | Molecular Biology Reports NQO1 in protection against oxidative

However, despite promising preclinical results, the clinical translation of SIN is limited by its poor pharmacokinetic profile, including low oral bioavailability and rapid systemic clearance

Appendix D Table 5

Curcumin has an excellent safety profile, with only mild gastrointestinal discomfort reported as the primary adverse effect, even at high doses (5008000 mg/day) and during long-term administration (up to 12 months)

It was also reported that the doxorubicin-mediated activation of p53 attenuated AIH by enhancing APAP transport and metabolism and inhibiting oxidative damage

Mammalian p50 Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4

[DOI] [PubMed] [Google Scholar] 150.Suarez-Rivero J.M., Pastor-Maldonado C.J., Povea-Cabello S., Alvarez-Cordoba M., Villalon-Garcia I., Munuera-Cabeza M., Suarez-Carrillo A., Talaveron-Rey M., Sanchez-Alcazar J.A